Zepp Health Corporation American depositary shares each representing sixteen Class A ordinary shares (ZEPP)

FairStock Score: 63/100 — STEADY

Key Financials

Strengths

• Revenue growth of 78.5% demonstrates strong top-line momentum

Concerns

• Altman Z-Score of 0.6 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Zepp Health Corporation American depositary shares each representing sixteen Class A ordinary shares is a micro-cap technology company valued at $240 million. Revenue stands at $259 million. From a quality standpoint, Zepp shows distressed Altman Z-Score of 0.6 warrants caution and negative ROE indicating losses. Growth dynamics show revenue growing at 78.5% and profit growth of 87.8%. Our composite FairStock Score of 63/100 reflects above-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Zepp's 78% revenue growth trajectory could accelerate as it captures additional market share in the technology sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the technology space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer